Search hospitals > Iowa > Des Moines
Medical Oncology and Hematology Associates-Des Moines
Claim this profileDes Moines, Iowa 50309
Global Leader in Parotid Gland Cancer
Global Leader in Relapse
Conducts research for Breast Cancer
Conducts research for Cervical Adenocarcinoma
Conducts research for Cancer
323 reported clinical trials
2 medical researchers
Summary
Medical Oncology and Hematology Associates-Des Moines is a medical facility located in Des Moines, Iowa. This center is recognized for care of Parotid Gland Cancer, Relapse, Breast Cancer, Cervical Adenocarcinoma, Cancer and other specialties. Medical Oncology and Hematology Associates-Des Moines is involved with conducting 323 clinical trials across 457 conditions. There are 2 research doctors associated with this hospital, such as Joshua Lukenbill and Robert J. Behrens.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Relapse
Global LeaderStage IV
Stage III
Stage I
Top PIs
Joshua LukenbillMedical Oncology and Hematology Associates-Des Moines2 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Cancer
140 reported clinical trials
215 drugs studied
Robert J. BehrensIowa Methodist Medical Center5 years of reported clinical research
Expert in Parotid Gland Cancer
Studies Cervical Adenocarcinoma
43 reported clinical trials
97 drugs studied
Clinical Trials running at Medical Oncology and Hematology Associates-Des Moines
Breast Cancer
Lung Cancer
Cancer
Parotid Gland Cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
Skin Cancer
Bladder Cancer
Squamous Cell Carcinoma
Breast cancer
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Medical Oncology and Hematology Associates-Des Moines?
Where is Medical Oncology and Hematology Associates-Des Moines located?
Who should I call to ask about financial aid or insurance network?
What insurance does Medical Oncology and Hematology Associates-Des Moines accept?
What awards or recognition has Medical Oncology and Hematology Associates-Des Moines received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.